APA (7th ed.) Citation

Zhao, X., Xu, Z., Mo, X., Chen, Y., Lv, M., Cheng, Y., . . . Huang, X. (2022). Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia, 36(1), 267-270. https://doi.org/10.1038/s41375-021-01351-w

Chicago Style (17th ed.) Citation

Zhao, Xiang-Yu, et al. "Preemptive Donor-derived Anti-CD19 CAR T-cell Infusion Showed a Promising Anti-leukemia Effect Against Relapse in MRD-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation." Leukemia 36, no. 1 (2022): 267-270. https://doi.org/10.1038/s41375-021-01351-w.

MLA (9th ed.) Citation

Zhao, Xiang-Yu, et al. "Preemptive Donor-derived Anti-CD19 CAR T-cell Infusion Showed a Promising Anti-leukemia Effect Against Relapse in MRD-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation." Leukemia, vol. 36, no. 1, 2022, pp. 267-270, https://doi.org/10.1038/s41375-021-01351-w.